Matthew K Fust

CRNX

Matthew K Fust serves as Director at Crinetics Pharmaceuticals, Inc. (CRNX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

11 trades

$4.87M

Net Position

Net Seller

$4.87M

Companies Traded

CRNX, NMRA, RARE, ATRA

Active Period

Jul 2021 – Sep 2025

11 total trades

Most Recent

Sell CRNX

Sep 26, 2025 · $716.0K

Matthew K Fust's Insider Trading at Crinetics Pharmaceuticals, Inc. (CRNX)

Buys

0 · $0.00

Sells

8 · $3.62M

Total Shares Bought

Total Shares Sold

99,200

CRNX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Sep 26, 2025	Sell	16,000	$44.75	$716.0K
Mar 20, 2024	Sell	47,500	$44.28	$2.10M
Jul 13, 2022	Sell	5,700	$20.96	$119.5K
Nov 1, 2021	Sell	8,954	$25.50	$228.3K
Sep 8, 2021	Sell	6,046	$25.50	$154.2K
Jul 26, 2021	Sell	5,000	$19.59	$98.0K
Jul 19, 2021	Sell	5,000	$19.50	$97.5K
Jul 12, 2021	Sell	5,000	$20.71	$103.5K

Matthew K Fust's Insider Trading at Ultragenyx Pharmaceutical Inc. (RARE)

Buys

0 · $0.00

Sells

1 · $620.4K

Total Shares Bought

Total Shares Sold

12,195

RARE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 11, 2024	Sell	12,195	$50.88	$620.4K	24,505

Matthew K Fust's Insider Trading at Neumora Therapeutics, Inc. Common Stock (NMRA)

Buys

0 · $0.00

Sells

1 · $371.0K

Total Shares Bought

Total Shares Sold

21,788

NMRA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Oct 18, 2024	Sell	21,788	$17.03	$371.0K	20,100

Matthew K Fust's Insider Trading at Atara Biotherapeutics, Inc. (ATRA)

Buys

0 · $0.00

Sells

1 · $260.4K

Total Shares Bought

Total Shares Sold

13,354

ATRA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 4, 2021	Sell	13,354	$19.50	$260.4K	0

Related Insiders

Jeff E. Knight

officer: Chief Operating Officer

CRNXSell · Apr 10, 2026

Howard Horn

officer: Chief Financial Officer

RARESell · Apr 2, 2026

Stephen F. Betz

officer: Chief Scientific Officer

CRNXSell · Mar 18, 2026

Richard Scott Struthers

President & CEO

CRNXSell · Mar 18, 2026

Coelho Rogerio Vivaldi

director

CRNXSell · Mar 13, 2026

Karah Herdman Parschauer

officer: EVP and Chief Legal Officer

RARESell · Mar 10, 2026

Michael Lee Milligan

See Remarks

NMRASell · Feb 19, 2026

BERNS PAUL L

See Remarks

NMRASell · Feb 19, 2026

Explore More Insider Trading Data

CRNX Insider Trading Activity

View all insider trades at Crinetics Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity